These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2850750)

  • 21. Therapeutic efficacy of itraconazole in systemic candidosis in guinea pigs.
    Van Cutsem J; Fransen J; Janssen PA
    Chemotherapy; 1987; 33(1):52-60. PubMed ID: 3030668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of dermatophytosis with new systemic antifungal agent, itraconazole.
    Noppakun N; Phuphaibool K
    J Med Assoc Thai; 1992 Feb; 75(2):99-103. PubMed ID: 1322949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats.
    Lou D; Cui X; Bao SS; Sun W; Pan WH; Chen MC; Dong YY; Hu GX; Chen RJ; Wang Z
    Drug Dev Ind Pharm; 2019 Apr; 45(4):689-693. PubMed ID: 30632818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of vehicle on corneal penetration of triturated ketoconazole and itraconazole.
    Guzek JP; Roosenberg JM; Gano DL; Wessels IF
    Ophthalmic Surg Lasers; 1998 Nov; 29(11):926-9. PubMed ID: 9824865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New antifungal agents in the treatment of superficial dermatomycoses].
    Degreef H
    Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of action studies. Basis for the search of new antifungal drugs.
    Vanden Bossche H; Marichal P; Gorrens J; Geerts H; Janssen PA
    Ann N Y Acad Sci; 1988; 544():191-207. PubMed ID: 2850749
    [No Abstract]   [Full Text] [Related]  

  • 27. Itraconazole pharmacokinetics in patients with renal dysfunction.
    Boelaert J; Schurgers M; Matthys E; Daneels R; van Peer A; De Beule K; Woestenborghs R; Heykants J
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1595-7. PubMed ID: 2847635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Itraconazole in antifungal therapy.
    Cleary JD; Taylor JW; Chapman SW
    Ann Pharmacother; 1992 Apr; 26(4):502-9. PubMed ID: 1315596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro antifungal activity of itraconazole: a comparative study with ketoconazole].
    Hiratani T; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):580-7. PubMed ID: 1652656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-Candida activity of azoles].
    Van Cutsem J; Van Gerven F; Janssen PA
    Ann Biol Clin (Paris); 1987; 45(6):661-8. PubMed ID: 2830810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
    Van Cutsem J
    Br J Clin Pract Suppl; 1990 Sep; 71():32-40. PubMed ID: 1965417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Itraconazole activity against fungal germination.
    Strippoli V; Simonetti N; Retico A; Lucchetti G
    Drugs Exp Clin Res; 1988; 14(5):341-5. PubMed ID: 2851427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
    Tucker RM; Denning DW; Hanson LH; Rinaldi MG; Graybill JR; Sharkey PK; Pappagianis D; Stevens DA
    Clin Infect Dis; 1992 Jan; 14(1):165-74. PubMed ID: 1315160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver injury associated with ketoconazole: review of the published evidence.
    Greenblatt HK; Greenblatt DJ
    J Clin Pharmacol; 2014 Dec; 54(12):1321-9. PubMed ID: 25216238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
    Kumar N; Shishu
    Eur J Pharm Sci; 2015 Jan; 67():97-112. PubMed ID: 25445834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New and prospective developments in antifungal drugs.
    Cauwenbergh G
    Acta Derm Venereol Suppl (Stockh); 1986; 121():147-53. PubMed ID: 3012922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sensitivity of Aspergillus to ketoconazole and itraconazole using a standardized micromethod].
    Guinet R; Marlier H
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):572-4. PubMed ID: 2166936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
    Uchida K; Matsuzaka A; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Itraconazole and fluconazole: new drugs for deep fungal infection.
    Warnock DW
    J Antimicrob Chemother; 1989 Sep; 24(3):275-7. PubMed ID: 2553654
    [No Abstract]   [Full Text] [Related]  

  • 40. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
    Perfect JR; Durack DT
    J Antimicrob Chemother; 1985 Jul; 16(1):81-6. PubMed ID: 2995303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.